Dermatofibrosarcoma Protuberans of the Lid with Orbital Invasion: The Challenges of Late Presentation
Article Sidebar
Main Article Content
Abstract
Background: Dermatofibrosarcoma Protuberans (DFSP) is a very rare painless intermediate to low grade malignancy of the subcutaneous tissue or dermis commonly seen in the young to middle age group and affecting the trunk and proximal extremities. The aim of this report is to present the rare lid affectation of the tumour and the challenges involved in managing a locally invasive tumour in the face of late presentation and financial constraints.
This is a case report of a 35-year-old woman who presented a 10 year history of Dermatofibrosarcoma Protuberans (DFSP) of the right lower lid with facial, maxillary, and orbital invasion of the right side. She underwent multiple surgeries, including orbital exenteration. There were limitations in accessing and following primary surgical procedures with radiation therapy and chemotherapy that could have impacted the overall outcome of this case.
Managing a DFSP in the presence of late presentation, marked local invasiveness and financial constraints is challenging. A multidisciplinary approach involving social workers must be employed if a cure is to be achieved.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
How to Cite
References
Leanne E, . What is Dermatofibrosarcoma Protuberans? http://sarcomahelp.org/dermatofibrosarcoma-protuberans.html#tpm1_1, Accessed on 23/01/2017.
Lemm D, Mügge L-O, Mentzel T, Höffken K. Current treatment options in dermatofibrosarcoma protuberans. Journal of cancer research and clinical oncology. 2009;135(5):653-665. doi:10.1007/s00432-009-0550-3. DOI: https://doi.org/10.1007/s00432-009-0550-3
Darier J, Ferrand M: Dermatofibromes progressifs et recidivants ou fibrosarcomes de la peau. Ann Dermatol Syphiliga 1924; 5:545-562.
Gloster HM. Dermatofibrosarcoma protuberans. Journal of the American Academy of Dermatology. 1996;35(3 Pt 1):355-374; http://www.ncbi.nlm.nih.gov/pubmed/8784271. DOI: https://doi.org/10.1016/S0190-9622(96)90597-6
Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, Brennan MF, Lewis JJ. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000;88(12):2711-2720. DOI: https://doi.org/10.1002/1097-0142(20000615)88:12<2711::AID-CNCR9>3.0.CO;2-M
Taylor HB, Helwig EB: Dermatofibrosarcoma protuberans: A study of 115 cases. Cancer 1962; 15:717-725. DOI: https://doi.org/10.1002/1097-0142(196207/08)15:4<717::AID-CNCR2820150405>3.0.CO;2-2
Krish T, Lester F. Dermatofibrosarcoma Protuberans (DFSP), http://www.dovemed.com/dermatofibrosarcoma-protuberans-dfsp/ Accessed on 23/01/2017.
Minter RM, Reith JD., Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change. J Surg Oncol. 2003;82(3):201-208. DOI: https://doi.org/10.1002/jso.10211
Kreicher KL, Kurlander DE, Gittleman HR, Barnholtz-Sloan JS. Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States. dermatol surge. 2006;42(1):24-31. DOI: https://doi.org/10.1097/DSS.0000000000000300
Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol. 2007;56(6):968-973. DOI: https://doi.org/10.1016/j.jaad.2006.09.006
Ratner D, Thomas CO, Johnson TM, Sondak VK, Hamilton TA, Nelson BR, Swanson NA, Garcia C, Clark RE GD. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multi-institutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol. 1997;37(4):600-613. DOI: https://doi.org/10.1016/S0190-9622(97)70179-8
Monsudi KF, Ibrahim MH, Ayodapo AO, Owoeye JFA, Na‘allah GR. Dermatofibrosarcoma Protuberans of the Scalp and Lid - A Huge Challenge: Case Report. Nigeria: World Journal of Biomedical Research [Internet]. 2023; 10(2):66-70.
Effiom OA, Olojede ACO, Akinde OR, Olawuyi AB, Amoo AT, Arotiba GT. Dermatofibrosarcoma protuberans: Clinicopathologic presentation in Nigerians. Pan African Medical Journal. 2018;31:25. doi:10.11604/pamj.2018.31.25.13665. DOI: https://doi.org/10.11604/pamj.2018.31.25.13665
Ogun GO, Ezenkwa US, Ayandipo OO. Dermatofibrosarcoma protuberance in a black African cohort - A clinicopathologic study. ecancermedicalscience. 2020;14:1086 doi:10.3332/ECANCER.2020.1086. DOI: https://doi.org/10.3332/ecancer.2020.1086
Laskin WB. Dermatofibrosarcoma protuberans. Ca-A Cancer Journal for Clinicians. 1992;42:116-125. DOI: https://doi.org/10.3322/canjclin.42.2.116
Angouridakis N, Kafas P, Jerjes W. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck. Head and Neck Oncology. 2011;3(1):3-5. DOI: https://doi.org/10.1186/1758-3284-3-5
Sanjay Bhambri, Avani Desai, James Rosso, Narciss Mobini. Dermatofibrosarcoma Protuberans A Case Report and Review of the Literature Sanjay Bhambri. J Clin Aesthet Dermatol. 2008;1(1):34-36.
Gloster HM Jr, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35(1):82-87.
Burud IA, How NS, CheeWei G, Roslina S. Dermatofibrosarcoma Protuberance of the Breast: a Diagnostic Challenge. Indian Journal of Surgery. 2017;79(2):169-172. doi:10.1007/s12262-016-1502-1. DOI: https://doi.org/10.1007/s12262-016-1502-1
Mani S, Kumar R, Kakkar A. Recurrent Dermatofibrosarcoma Protuberans of the Head and Neck: A Case Series. Indian Journal of Surgical Oncology. 2023;14(1):128-136. doi:10.1007/s13193-022-01636-1. DOI: https://doi.org/10.1007/s13193-022-01636-1
Ali S, Ahmad I, Yaseen M, Sudhy I. Recurrent dermatofibrosarcoma protuberance: A single-center analysis. Turkish Journal of Plastic Surgery. 2023;31(4):136. doi:10.4103/tjps.tjps_30_23. DOI: https://doi.org/10.4103/tjps.tjps_30_23
Ballo MT, Zagars GK, Pisters P, Pollack A. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. International journal of radiation oncology, biology, physics. 1998;40(4):823-827. doi:10.1016/S0360-3016(97)00895-X. DOI: https://doi.org/10.1016/S0360-3016(97)00895-X
Abrams TA, Schuetze SM. Targeted therapy for dermatofibrosarcoma protuberans. Current Oncology Reports. 2006;8(4):291-296. doi:10.1007/s11912-006-0035-3. DOI: https://doi.org/10.1007/s11912-006-0035-3
Alawode GO, Adewole DA. Assessment of the design and implementation challenges of the National Health Insurance Scheme in Nigeria: a qualitative study among sub-national level actors, healthcare and insurance providers. BMC Public Health. 2021;21(1):124-125. doi:10.1186/s12889-020-10133-5. DOI: https://doi.org/10.1186/s12889-020-10133-5